N-Methyl-1-(2-(methylsulfinyl)pyrimidin-4-yl)methanamine

Catalog No.: 
ACDCEK235
CAS No.: 
1823930-80-8
Molecular Formula: 
C7H11N3OS
Molecular Weight: 
185.25
N-Methyl-1-(2-(methylsulfinyl)pyrimidin-4-yl)methanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$808.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-Methyl-1-(2-(methylsulfinyl)pyrimidin-4-yl)methanamine
IUPAC NameN-methyl-1-(2-(methylsulfinyl)pyrimidin-4-yl)methanamine
Molecular FormulaC7H11N3OS
Molecular Weight185.25
SMILESO=S(C1=NC=CC(CNC)=N1)C
InChI KeyKVNJUTCBGNZYCQ-UHFFFAOYSA-N
SynonymN-Methyl-1-(2-(methylsulfinyl)pyrimidin-4-yl)methanamine;4-Pyrimidinemethanamine, N-methyl-2-(methylsulfinyl)-
CAS No.1823930-80-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACDCEK235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDCEK235 route product structure diagram
    ACDCEK2351823930-80-8
Inquiry

2. ACDCEK235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDCEK235 route product structure diagram
    ACDCEK2351823930-80-8
Inquiry

3. ACDCEK235 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDCEK235 route product structure diagram
    ACDCEK2351823930-80-8
Inquiry

Comments (0)